Who is the largest shareholder of Myriad Medical

Myriad Medical's largest shareholder is Smartco Development Limited, share type restricted circulation A shares, shareholding: 32,707.23 million shares, shareholding ratio: 26.90%, increase or decrease (shares) unchanged, Myriad BioMedical is a domestic leader in medical devices, is committed to providing quality products and services for global healthcare organizations main business The main businesses of Myriad Biomedical cover a wide range of fields such as life information and support, in vitro diagnostics, medical imaging, surgery, orthopedics, animal medicine, and so on. Among them, most of the sub-products of life information and support business, such as monitors, defibrillators, anesthesia machines, ventilators, infusion pumps, and blood cells of in-vitro diagnostic business, have become the No. 1 in China. Based on the comprehensive medical device product line, the company has successively launched three major IT solutions, namely Ruizhilian, Ruizhi Inspection, and Ruixiangyun, to promote the construction of smart hospitals.

A, Myriad Medical basic introduction

1, the plate medical equipment Ning portfolio Mao index FTSE Russell in vitro diagnostic unicorn SZSE 100R GEM comprehensive MSCI China SZSE medical device concept entrepreneurial constituents financing financing SZSE 500 SZZZ HS300_ Guangdong plate

2, the scope of business production and operation of medical electronic instruments and their supporting reagents and product software development Reagents and products and software development (excluding state-restricted projects); self-produced products, after-sales service, rental of their own homes; engaged in the import and export of goods and technology.

3, medical equipment: the company's main products cover three major areas, including life information and support, in vitro diagnostics and medical imaging, currently has a rich product category.

Second, Myriad Healthcare's technology solutions

1, first aid total solution is committed to "high-quality first aid", around the first aid process and challenges in the development of innovative products, to complete the pre-hospital and in-hospital integration of high-efficiency information to achieve high-quality resuscitation purposes.

2. Perioperative total solution matches the three phases of clinical preoperative induction, intraoperative maintenance and postoperative resuscitation, and helps to improve perioperative safety and efficiency with the goal of "accurate perioperative".

3. The overall solution for critical care is oriented towards "intelligent ICU", which utilizes intelligent technology to assist in clinical decision-making and treatment of critical care, and utilizes information technology to realize efficient interconnection of bedside information, intra-departmental information and hospital-wide information, so as to build a safe department.